DRAPER, Utah, Jan. 6, 2014 /PRNewswire/ -- Nutranomics,
Inc. (OTCBB: NNRX) (OTCQB: NNRX) ("Nutranomics" or the "Company")
is pleased to report that it has received a repeat purchase order
from one of the world's largest essential oil direct sales
distribution companies.
This latest purchase order is for three separate Nutranomics
products and constitutes in excess of $240,000 in revenue for the Company.
Due to the sensitive and competitive nature of the
market, Nutranomics cannot disclose the name of this customer and
further details regarding the order.
"As a research and development facility, it's always a positive
sign that a product that we have developed gets a repeat order from
a customer. It usually means that the market is receiving it
well and that customers are getting the results that they are
looking for," said Mike Brousseau,
General Manager of Nutranomics. "Maintaining and expanding
this ongoing relationship will remain a high priority for the
Company, and we intend to utilize all of our sales and product
development expertise to assist this client in their future
growth."
The Company anticipates that all three of these products will
continue to be steady sellers for this client in the foreseeable
future and that additional product re-orders are probable.
About Nutranomics
Nutranomics is a publicly traded company engaged in research and
development of nutritional food products. In 1997,
Nutranomics produced and branded its own product line, and began to
sell to the retail outlets and to the public. Nutranomics has
also produced formulas for hundreds of other companies.
Nutranomics' mission is to increase human health and longevity
through education and self-awareness. The Company has sales
representatives throughout North
America and Asia.
For further information regarding Nutranomics, Inc., please
contact our investor relations representatives at
ir@nutranomics.com or call toll-free (888) 616-3999.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements."
Statements in this press release that are not purely historical are
forward-looking statements and include any statements regarding
beliefs, plans, expectations or intentions regarding the
future. Such forward-looking statements include the Company's
expectation that the products mentioned will continue to be steady
sellers for the client and that the client will place additional
product re-orders. Actual results could differ from those
projected in any forward-looking statements due to numerous
factors. Such factors include, among others, the inherent
uncertainties associated with developing new products and operating
as a development stage company, our ability to raise the additional
funding we will need to continue to pursue our business and product
development plans, competition in the industry in which we operate
and market conditions. These forward-looking statements are
made as of the date of this news release, and we assume no
obligation to update the forward-looking statements, or to update
the reasons why actual results could differ from those projected in
the forward-looking statements, except as required by applicable
law, including the securities laws of the United States.
Although we believe that any beliefs, plans, expectations and
intentions contained in this press release are reasonable, there
can be no assurance that any such beliefs, plans, expectations or
intentions will prove to be accurate. Investors should
consult all of the information set forth herein and should also
refer to the risk factors disclosure outlined in the reports and
other documents we file with the SEC, available at
www.sec.gov. These statements have not been evaluated by the
Food and Drug Administration. These products are not intended
to diagnose, treat, cure or prevent any disease.
SOURCE Nutranomics, Inc.